What it sells
AI infrastructure for biosecurity
Business model breakdown
Trigger: what makes them buy now?
Regulation mandating dual-use screening (EU Biotech Act, US executive orders) as synthetic biology and AI-bio scale.
Distribution: how it reaches customers
Partner-led ("Partner with us").
Funding history and coverage
| Round date | Stage | Amount | Investors | Source |
|---|---|---|---|---|
| — | Y Combinator Summer 2025 | — | Y Combinator | ycombinator.com |
Profiles summarize public reporting and company websites. Business-model notes are MaxBC's reading of that material, not confirmed facts; unknowns are left blank rather than guessed. Updated 2026-10-12.